Urine Omics Predicting IO Therapy Responses in mRCC Patients

Abroad (travel likely)Recruiting

Conditions

Metastatic Renal Cell Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

National Taiwan University Hospital, Taipei, Taiwan
Contact: Study coordinator (Yeong Shiau Pu, MD PhD) · pu5249@ntuh.gov.tw · 886-2-23123456
Contact: Study coordinator (Chung Hsin Chen,, MD PhD) · mufasachen@gmail.com · 886-2-23123456

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma

Metastatic Melanoma · Advanced Locoregional Melanoma · Metastatic Renal Cell Carcinoma

Abroad (travel likely)RecruitingPHASE2

Bethesda, United States

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

Advanced Breast Carcinoma · Advanced Endometrial Carcinoma · Advanced Fallopian Tube Carcinoma

Abroad (travel likely)RecruitingPHASE1

Houston, United States

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Diffuse Astrocytoma, IDH-Mutant · Glioblastoma, IDH-wildtype · Brain Metastases, Adult

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beverly Hills, United States · Glendale, United States

Digital Monitoring of Self-reported Symptoms by Patients Treated With Cabozantinib Plus Nivolumab for Advanced Clear-cell Renal Carcinoma

Renal Cell Carcinoma (Kidney Cancer) · Metastatic Renal Cell Carcinoma · Locally Advanced

Abroad (travel likely)RecruitingPHASE4

Annecy, France · Avignon, France